University certificate
The world's largest faculty of medicine”
Description
Develop your skills and knowledge with this prestigious training provided by experts in the field"
Cardiac toxicity (CT) occurs in up to 30% of the millions of patients treated today for oncological processes. This is a "serious complication that usually manifests as heart failure and negatively affects the prognosis" of patients. The onset and severity of CT related to oncologic treatment are varied, depending mainly on each patient's individual susceptibility, the mechanism of action of the therapy, the capacity for early detection and the establishment of targeted treatment.
The objective of this course is to offer updated training in an area of current relevance from the clinical point of view, whose knowledge is advancing at a dizzying pace, focused on the training of professionals interested in the subject.
Cardiologists, oncologists and hematologists with special interest in this field have with this course the opportunity to complete and update their knowledge in oncologic cardiology. The final objective of this training will be that students learn the pathophysiological basis of the genesis of CT, as well as the ways to detect and treat it. Students will get to know, understand and apply the latest diagnostic techniques, and preventive and therapeutic measures specific to CT in oncology patients.
Emphasis will be placed on solving complex clinical problems by performing case studies based on real-life situations. In addition, it offers a unique opportunity to learn about the latest research advances in this high-demand field.
Learn about the latest advances in the specialty to be able to perform a quality medical practice"
This postgraduate certificate in Risk Assessment and Early Detection of Cardiotoxicity in the Oncology Patient, offers you the characteristics of a course of high scientific, teaching and technological level. These are some of its most notable features:
- Latest technology in online teaching software
- Highly visual teaching system, supported by graphic and schematic contents that are easy to assimilate and understand
- Practical cases presented by practising experts
- State-of-the-art interactive video systems
- Teaching supported by telepractice
- Continuous updating and recycling systems
- Self-regulating learning: full compatibility with other occupations
- Practical exercises for self-evaluation and learning verification
- Support groups and educational synergies: questions to the expert, debate and knowledge forums
- Communication with the teacher and individual reflection work
- Content that is accessible from any fixed or portable device with an Internet connection
- Banks of complementary documentation permanently available, even after the course
This course may be the best investment you can make in the selection of a refresher program for two reasons: in addition to updating your knowledge in Risk Assessment and Early Detection of Cardiotoxicity in the Oncology Patient, you will obtain a course certificate from TECH Global University"
Our teaching staff is composed of professionals belonging to the field of Oncologic Cardiology. In this way, we ensure that we provide you with the training update we are aiming for. A multidisciplinary team of doctors trained and experienced in different environments, who will develop the theoretical knowledge in an efficient way, but, above all, will put at the service of the Course the practical knowledge derived from their own experience: one of the differential qualities of this Course.
This mastery of the subject is complemented by the effectiveness of the methodological design of this course. Developed by a multidisciplinary team of e-learning experts, it integrates the latest advances in educational technology. This way, you will be able to study with a range of comfortable and versatile multimedia tools that will give you the operability you need in your training.
The design of this program is based on Problem-Based Learning: an approach that conceives learning as an eminently practical process. To achieve this remotely, we will use telepractice: With the help of an innovative interactive video system, and learning from an expert, you will be able to acquire the knowledge as if you were actually dealing with the scenario you are learning about. A concept that will allow you to integrate and fix learning in a more realistic and permanent way.
It includes clinical cases that bring the development of the program as close as possible to the reality of medical care"
You will have professionals in the sector to guide you throughout the training process"
Objectives
The objective of this training is to train highly qualified professionals for work experience. An objective that is complemented, moreover, in a global manner, by promoting human development that lays the foundations for a better society. This objective is focused on helping medical professionals reach a much higher level of expertise and control. A goal that, in only 2 months, you will be able to achieve, with a high intensity and precision course.
Develop your skills and abilities in Oncologic Cardiology with this highly scientifically rigorous program"
General Objectives
- Update Cardiologists, Oncologists, and Hematologists's knowledge in the field of Cardio-Oncology
- Promote work strategies based on a comprehensive approach to the patient as a standard model for achieving excellent care
- Encourage the acquisition of technical skills and abilities, through a powerful audiovisual system, and the possibility of development through online simulation workshops and/or specific training
- Promote professional stimulation through continuing education and research
- Identify individual susceptibility factors, both genetic and acquired, for the occurrence of cardiac toxicity
- Perform a comprehensive risk assessment of the patient who is going to undergo oncologic treatment
- Describe the monitoring required by patients during treatment with cardiotoxic therapies
- Recognize the risk factors for the development of ischemic heart disease in patients who have received thoracic radiotherapy
Learn new diagnostic and therapeutic procedures from specialists in the field"
Postgraduate Certificate in Risk Assessment and Early Detection of Cardiotoxicity in the Oncology Patient
In the health field, it is essential to have trained professionals to provide comprehensive care to oncology patients. The Postgraduate Certificate in Risk Assessment and Early Detection of Cardiotoxicity in the Oncology Patient from TECH Global University provides you with the necessary knowledge to efficiently address the challenges associated with cardiotoxicity in patients receiving oncology treatments.
Our online class program allows you to access quality training from the comfort of your home. At TECH Global University, we understand the importance of flexibility in learning and that is why we have designed a Postgraduate Certificate that adapts to your schedule and needs. Through our online platforms, you will have access to cutting-edge educational resources and you will be able to interact with expert professionals in the field of oncology and cardiology.
Become an expert in the cardiac care of oncology patients.
The Postgraduate Certificate focuses on assessing the risk of cardiotoxicity in oncology patients, as well as early detection of the adverse effects that treatments can have on the cardiovascular system. You will learn to identify risk factors and use assessment tools to detect early any signs of cardiac toxicity. In addition, you will become familiar with the latest research and advances in the field of oncologic cardiology, allowing you to provide more comprehensive and personalized care to your patients.
Stand out in the field of oncology care and become a highly trained professional in risk assessment and early detection of cardiotoxicity in the oncology patient. Enroll now in the Postgraduate Certificate in Risk Assessment and Early Detection of Cardiotoxicity in the Oncology Patient from TECH Global University and acquire the skills you need to make a difference in the lives of those battling cancer.